Evaluation of haemoglobin A1c measurement by an enzymatic method using an automated analyser that has an on-board haemolysis system.
Matsumoto H, Uchino M, Kato M
Purpose
Conclusion
Studies (1)
Purpose
The purpose of this study was to determine the effects of sampling location within the erythrocyte pack and measurement method on levels of HbA1C in blood from inpatients, outpatients and hospital employees.
Summary of Findings
Regardless of sampling location relative to the bottom of the tube, measured levels of HbA1C were comparable when by the enzymatic assay based BM6010/C and the HPLC based Tosoh G7. The authors report no effect of exogenous acetylated Hb, carbamylated Hb and labile HbA1c on measurement of HbA1c. Levels of HbA1c measured by the BM6010/C were very strongly correlated with those measured by the Primus HPLC (r2=0.997) and Tosoh G7 HPLC (r=0.994), but a bias of 0.6-3.3% was observed using the BM6010/C.
Biospecimens
CellRed Blood CellsPreservation Types
None (Fresh)Diagnoses
NormalNot specifiedPlatforms
ProteinClinical chemistry/auto analyzerProteinHPLCPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Aliquots and Components Biospecimen components 0-10 g/L labile HbA1c added0-500 mg/L acetylated Hb added0-500 mg/L carbamylated Hb added1 mm from bottom3 mm from bottom5 mm from bottomBiospecimen Aliquots and Components Blood and blood products Multiple sampling positions examinedClinical chemistry/auto analyzer Specific Technology platform BM6010/CPrimus HPLCTosoh G7 HPLC